Standard BioTools Inc. ( LAB) - Key Metrics
LAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | -$0.07 | -$0.03 | -$0.03 |
| 2026Q1 | $0.05 | -$0.12 | -$0.12 | -$0.12 |
| 2025Q4 | $0.06 | $0.05 | $0 | $0 |
| 2025Q3 | $0.05 | -$0.09 | -$0.06 | -$0.06 |
| 2025Q2 | $0.06 | -$0.09 | -$0.05 | -$0.06 |
LAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.94 |
| 2026Q1 | 0% | -1.92 |
| 2025Q4 | 0% | 6.39 |
| 2025Q3 | 0% | -3.59 |
| 2025Q2 | 0% | -3.33 |
LAB
Price: $0.64
52 week price:
Earnings Per Share: -0.13 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 309.7 million